[an error occurred while processing this directive]
Read this story in English | Add a translation >>

The major media is finally covering the toxicity of what pharmaceutical companies mislabel 'AIDS Drugs,' but they're four years and hundreds of deaths too late.

This week, Dr. Edmund Tramont, Head of the National Institutes of Health (NIH) AIDS division, was outed by fellow NIH AIDS researcher Dr. Jonathan Fishbein, for burying evidence of drug toxicity in an African drug trial. Tramont censored reporting of thousands of toxic reactions and at least 14 deaths in the ongoing Nevirapine study in Uganda.

The media has seized on this like it’s news, but the truth about Nevirapine was known in 2000, when the FDA put a black-box label on the drug, warning of the drug’s ability to cause fatal liver damage and bloody rupturing of skin and flesh.

The drug’s manufacturer, Boehringer Ingelheim, wanted to get the drug into the US market for use in pregnant HIV-positive women. But the drug’s toxicities were so great, they pulled it out of the FDA approval process. Then they did what all drug companies do with their garbage – dump it into impoverished foreign markets and tell the soft-headed liberal media that it’s an AIDS drug.

The Ugandan study that Tramont helped bury was overseen by Dr. Laura Guay, a US doctor from Johns Hopkins University School of Medicine. Under Dr. Guay, the drug found its approval overseas. How does a drug that kills Americans save Africans?

South African lawyer and journalist Anthony Brink scrutinized the study in "The Trouble With Nevirapine" first published in April 2002, and updated this year. Dr. Fishbein tracked down Brink, whose study he described as "an expertly written piece about this very dangerous drug."

There’s not a word in the current NIH mea culpa that Brink didn’t outline in greater detail a year and a half ago.

The Ugandan study started like all AIDS drug trials do. Dr.Guay discarded the study controls. There was no placebo group to compare the Nevirapine group to. Everybody was on one of two cell-killing drugs – Nevirapine or AZT.

The study put pregnant women on one of the two pills at labor. Why at labor? The idea is to prevent transmission of HIV from mother to child. The mother’s HIV status is determined, of course, by what we call an HIV antibody test.

Here’s a clever bit of information left out of the NIH report and the mainstream press coverage - HIV test inserts warn that pregnancy produces antibodies which cause the tests to come up positive. Pregnancy, on its own, creates positive HIV test results. You’ll find this over and over again in the medical literature. But it was ignored in Uganda (as it is in the US, every day).

The other line of missing logic in the Ugandan study is that, according to the test manufacturers, no child can be tested for at least 18 months with any certainty, because of normal “passive transmission of maternal antibodies” that can trip up the hyper-reactive HIV tests.

So, what are we trying to prevent transmission of? Antibodies? Pregnancy? Who knows.

In order to get around the standard tests’ short-comings, the babies were instead tested with a genetic kit called PCR. But here’s the joke. PCR isn’t validated or approved to diagnose viral infection.

PCR is irreproducible. In the lab, it gives wildly varying results for the same sample. There’s no standard to measure it against.

PCR tests amplify scraps of unidentifiable genetic material in cells. Researchers like to pretend that this material represents some aspect of a virus – but the manufacturer warns specifically against using the test for this purpose:

“The AMPLICOR HIV-1 MONITOR Test….is not intended to be used as a screening test for HIV or as a diagnostic test to confirm the presence of HIV infection.” (Roche PCR HIV-1 Monitor Test)

But that’s exactly how doctors and researchers are using it, to get infants into a drug study.

Where’s the liberal media on this issue - Mother Jones, Democracy Now? I’ve presented it to DN, several times, and apparently, they can’t be bothered with it. After all, how could the medical establishment be wrong?

But even if the tests were accurate, and the drugs weren’t biological weapons, there’s a terrible flaw in these studies. To paraphrase Brink - what’s the purpose of a last-minute drugging to prevent the passage of a retrovirus, when the child and mother have been sharing the same blood, tissue, cells and body for nine months?

Adding insult to injury, the Guay study also became immediately unblinded. Everybody knew who was on Nevirapine, who was on AZT, and who tested positive. In the absence of a controlled, well-observed study, participants tend to give into panic, pill-sharing, over-consuming, and the mixing in of non-study drugs to try to get the HIV-antibody response to go away.

The results of Guay’s study came in with an official recommendation for Nevirapine, but only after recording a 20% rate of “serious adverse events” in both the Nevirapine and AZT groups. Patients on the drugs had blood and tissue infection, pneumonia, blood cell death, severe rash and insufficient oxygen reaching their tissues.

Thirty-eight babies died. Sixteen on Nevirapine, twenty-two on AZT.

The drug was approved because the rate of PCR-inferred viral infection in the Nevirapine infants was 13.1%. Lower than that of the AZT group’s PCR rating. What’s PCR? A non-diagnostic test with no standard that gives different results for every sample.

According to the medical/pharmaceutical establishment, it was enough to get a profitable, deadly drug into the international marketplace. (Dead babies don’t mean much there).

If that doesn’t penetrate your skull, try this. A study was done in 1998 with 561 expectant African mothers to see what the rate of presumed HIV infection was with no drugs, no pills and no placebos. The result – 12%. Less than 13.1? Sure. But where’s the money in not drugging them?

This summer in America, the same drug was being used in an NIH sponsored trial of US patients. Another expectant mother, Joyce Ann Hafford, had been dosed with Nevirapine (commercially sold here as “Viramune”) because she too had a reaction on an HIV test.

Hafford was 33. Before entering the study, she was healthy and pregnant, but was convinced to go on the drug because of her HIV test result. In early August doctors knew that Hafford’s liver was failing. But they kept her on the drugs.

She died two weeks later due to “drug-induced hepatitis” – fatal liver poisoning. An emergency cesarean-section was performed to get her baby out of her dying body. Neither she nor her family had been given the drug’s boxed warning label prior to her entrance into the study. If she had, she might be here today.

The Nevirapine (Viramune) label:
“Warning: Severe, life-threatening, and in some cases fatal hepatotoxicity [liver poisoning], including fulminant and cholestatic hepatitis, hepatitic necrosis [liver death] and hepatatic [liver] failure, has been reported in patients treated with VIRAMUNE [Nevirapine]…Patients with signs or symptoms of hepatitis must discontinue VIRAMUNE and seek medical evaluation immediately.

Severe, life-threatening skin reactions, including fatal cases, have occurred in patients treated with VIRAMUNE. These have included cases of Stevens-Johnson syndrome, toxic epidermal necrolysis [skin death], and hypersensitivity reactions characterized by rash, constitutional findings and organ dysfunction.

It is essential that patients be monitored intensively during the first 18 weeks of therapy with VIRAMUNE to detect potentially life-threatening hepatotoxicity or skin reactions….In some cases, hepatatic injury has progressed despite continuation of treatment. VIRAMUNE should not be restarted following severe hepatatic, skin, or hypersensitivity reactions.”

Dr. Edmund Tramont, of the NIH, had these thoughtful words to offer on the subject.
"Ouch! Not much wwe (we) can do about dumd (dumb) docs," he wrote, in an inner-office email, leaked to the Associated Press.

“Ouch! Not much we can do about dumb docs?”

Sure there is. We can take them to court. In droves.

But maybe it’s time that the rest of us got smart, and began to regard the NIH with the same unblinking critical eye that we do any other money-driven corporate entity. The day that the Left stops pretending that the NIH is going to solve the world’s health problems, we might actually start saving some lives.

For more on Nevirapine, see the 2001 European Study photos and link at "Altheal.org": http://www.altheal.org/toxicity/orphans.htm

- e-mail:: liam_scheff@hotmail.com

Please Don't Feed the Trolls

Wikipedia defines an Internet Troll as: "either a person who sends messages on the Internet hoping to entice other users into angry or fruitless responses, or a message sent by such a person." San Diego IMC strives to provide both a grassroots media resource as well as a forum for people to contribute to a meaningful discussion about local issues. Please, when posting comments, be respectful of others and ignore those trying to interrupt or discourage meaningful discourse. Thank you.

-- San Diego Indymedia volunteers
  Download this article in pdf format >>

  Make a quick comment on this article>>

Liam Scheff should learn some medicine

19.12.2004 19:45

Sadly Mr Scheff needs to learn some basic medicine, and read the HIVNET012 study protocol.

1. The placenta is designed to prevent maternal and fetal blood from mixing. HIV only rarely infects DURING pregancy. C-section can prevent infection, since it mostly occurs as the baby travels down the birth canal. Treating at the time of birth therefore makes good sense.

2. Pregnancy causes very rare false-positive reactions on the HIV tests. One recent study put it at 0.44% in a "high" rate group. Also the Ugandan study used full US-style testing with confirmatory Western Blot, not just rapid ELISA.

3. The tests used for neonatal diagnosis are used routinely: not every RNA test is unapproved in diagnosis! One was approved in September 2001 by the FDA for the purpose of screening samples. Additionally the infections in infants were actually confirmed by additional RNA tests, virus cultures, and serology after the magical 18 month value Mr Scheff mentions.

4. Nevirapine is still approved to treat HIV, despite what he says in the article. The toxicity problem is no different from, say, Tylenol which also causes fatal liver toxicity. The study problem he rightly enough draws attention to is not one of AIDS drugs, but one of study docs (in this single instance) not paying enough attention to their patients.

The study protocol is freely available online at

There really should be no excuse for mis-representing it.


e-mail:: njb35@cantab.net
Homepage:: njb35@cantab.net

Bennet, you are a bloody idiot

04.01.2005 22:57

I've read the article, and read the comment by Bennet.

It's hard to know what to say to a guy who's willing to dispute that 40 (plus 15 or more) dead infants is a bad thing.

It's hard to know what to say to a guy who's willing to say that three or more non-functional, cross-reactive antibody or genomic test are better than one.

It's hard to know what to say to a guy who says that a virus won't pass the placenta, at the same time he defends the practice of drugging infants and their birthing mothers with a skin-peeling, blood vessel bursting drug, because the virus that won't pass the placenta needs to be stopped -

Bennet, are you retarded? Or just a tool for the pharmaceutical companies?

And what about that 'magical' 18 month period. The writer didn't make that up, that's found on the inside of HIV tests. If it's so meaningless, then at what point is this whole line of testing for antibodies to prove a virus supposed to be meaningful? - Especially when there's no damn standard for measuring these tests.

Is there a limit that you won't go to defend the cooked, corrupt science that marrs the industry at present?

Is there anything that's not okay with you, if someone in a lab coat is doing it?

Tell me when you wake from your state of childish belief in the medical deities.


Sam Simon
e-mail:: simonosy@hotmail.com

Stories contributed to this site are licensed under the
Creative Commons Non Commercial - Share Alike - By Attribution license
unless otherwise specified by the author.